Full-Time

Senior Safety Data Sheet Specialist

Updated on 7/11/2025

Deadline 7/25/25
AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior

Buxton, UK

In Person

Minimum of three days per week in the office.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Degree in a science-related discipline, or equivalent experience
  • Extensive expertise in Global Chemical Regulations, particularly CLP or GHS
  • Proven experience in the creation of Safety Data Sheets
  • Excellent communication and influencing skills, with the ability to engage effectively with stakeholders
  • Strong project and people management skills, with experience leading cross-functional initiatives
Responsibilities
  • Production and management of Safety Data Sheets for AstraZeneca, ensuring compliance with local, national and regional regulations
  • Collaborate with AstraZeneca experts worldwide to obtain the information required for accurate hazard assessments
  • Provide technical support and guidance to internal teams on complex regulatory queries
  • Identify and implement opportunities for continuous improvement in hazard communication practices
Desired Qualifications
  • Experience in SAP EH&S authoring platform
  • Previous experience in the pharmaceutical industry
  • Experience and understanding of the Dangerous Goods regulations

AstraZeneca focuses on discovering, developing, and selling prescription medicines, primarily in three areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Their products are developed through extensive research and development, which includes rigorous clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and fostering collaborations through initiatives like their Open Innovation program, which shares resources with the scientific community to speed up drug discovery. The company's goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through strategic partnerships.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery boosts precision biologics development with Sortera Bio.
  • Expansion in Bangalore strengthens AstraZeneca's presence in emerging markets.
  • Partnership with Danaher advances precision medicine diagnostics.

What critics are saying

  • Increased competition in oncology from Bristol-Myers Squibb and Merck.
  • Patent expirations, like Symbicort, threaten revenue with potential generic competition.
  • Regulatory challenges in China could hinder AstraZeneca's growth prospects.

What makes AstraZeneca unique

  • AstraZeneca's Open Innovation program accelerates drug discovery through shared resources.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Strategic partnerships enhance AstraZeneca's research capabilities and product portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

CardioPhoenix
Jul 11th, 2025
Heart Health in 10 Minutes: Cardio-HART Saves Lives at "Diagnósticos F.C.", AstraZeneca

Last week, Cardio-Phoenix partnered with AstraZeneca for a transformative day of community heart-health screening at the "Diagnósticos F.C." event held at the BAKH Sports Center in Vitoria.

HRKatha
Jun 27th, 2025
AstraZeneca creates 400 jobs, expands its global hub in Bangalore

AstraZeneca creates 400 jobs, expands its global hub in Bangalore.

Devdiscourse
Jun 18th, 2025
AstraZeneca's Stake in Niox Group: A Strategic Partnership | Headlines

AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move signals strategic collaboration opportunities between the two companies, potentially aligning their interests in the pharmaceutical industry and expanding their influence in the sector.

InfBusiness
Jun 17th, 2025
Scientists present AI solution for protein folding

Scientists from the University of Sheffield, in partnership with AstraZeneca, have developed an artificial intelligence system called MapDiff, which allows for more efficient creation of proteins with a giventhree-dimensional structure and biological functions.

Cision
Jun 13th, 2025
Astrazeneca Enters Into Collaboration With Cspc

AstraZeneca enters into collaboration with CSPC